drugset / Trial / NCT05331664

Dropless Pars Plana Vitrectomy Study

NCT05331664

Phase 4 Recruiting 168 enrolled Massachusetts Eye and Ear Infirmary
RandomizedParallel-groupOpen-labelTreatment

Summary

To demonstrate that intraoperative use of subtenon triamcinolone acetonide at the time of surgery without postoperative eye drops is non-inferior to the regimen of postoperative eye drops following primary pars plana vitrectomy for retinal detachment.

Timeline

Start
2022-07-25
Primary completion
2026-07-25
Completion
2027-01-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 1 % Topical
Comparator Moxifloxacin Small molecule 0.5 % Topical
Comparator Prednisolone Other / unclassified 1 % Topical
Comparator Triamcinolone Acetonide Other / unclassified 40 mg/ml Other
Comparator Trimethoprim Small molecule Topical